Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod von Montarolo, F., Perga, S., Martire, S., Brescia, F., Caldano, M., Lo Re, M., Panzica, G., Bertolotto, A.

Volltext

Predictive markers for response to interferon therapy in patients with multiple sclerosis von MALUCCHI, S, GILLI, F, CALDANO, M, MARNETTO, F, VALENTINO, P, GRANIERI, L, SALA, A, CAPOBIANCO, M, BERTOLOTTO, A

Volltext

Biological monitoring of IFN-β therapy in Multiple Sclerosis von Bertolotto, A, Granieri, L, Marnetto, F, Valentino, P, Sala, A, Capobianco, M, Malucchi, S, Di Sapio, A, Malentacchi, M, Matta, M, Caldano, M

Volltext

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1 von Gilli, F, Marnetto, F, Caldano, M, Sala, A, Malucchi, S, Capobianco, M, Bertolotto, A

Volltext

Expression and regulation of IFNα/β receptor in IFNβ-treated patients with multiple sclerosis von GILLI, F, VALENTINO, P, CALDANO, M, GRANIERI, L, CAPOBIANCO, M, MALUCCHI, S, SALA, A, MARNETTO, F, BERTOLOTTO, A

Volltext

Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta von Bertolotto, A., Sala, A., Caldano, M., Capobianco, M., Malucchi, S., Marnetto, F., Gilli, F.

Volltext

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies von Bertolotto, A, Sala, A, Malucchi, S, Marnetto, F, Caldano, M, Di Sapio, A, Capobianco, M, Gilli, F

Volltext

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis von Gilli, F., Marnetto, F., Caldano, M., Sala, A., Malucchi, S., Di Sapio, A., Capobianco, M., Bertolotto, A.

Volltext

P14.27 Exploring end-of-life care in the GlioCova national brain tumour patient cohort von Mauricaite, R, Le Calvez, K, Droney, J, Caldano, M, Alam, M, Williams, M

Volltext

Interferon-β bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice von van der Voort, LF, Kok, A, Oudejans, CBM, Caldano, M, Gilli, F, Bertolotto, A, Polman, CH, Killestein, J

Volltext

Qualitative and quantitative analysis of antibody response against IFNβ in patients with multiple sclerosis von Gilli, F, Hoffmann, F, Sala, A, Marnetto, F, Caldano, M, Valentino, P, Kappos, L, Bertolotto, A, Lindberg, R LP

Volltext

Study of the NR 4A family gene expression in patients with multiple sclerosis treated with Fingolimod von Montarolo, F., Perga, S., Martire, S., Brescia, F., Caldano, M., Lo Re, M., Panzica, G., Bertolotto, A.

Volltext

Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments von Malucchi, S, Capobianco, M, Gilli, F, Marnetto, F, Caldano, M, Sala, A, Bertolotto, A

Volltext

Interferon-p bioactivity measurement in multiple sclerosis : feasibility for routine clinical practice von VAN DER VOORT, L. F, KOK, A, VISSER, A, OUDEJANS, C. B. M, CALDANO, M, GILLI, F, BERTOLOTTO, A, POLMAN, C. H, KILLESTEIN, J

Volltext

Anti-interferon-^b neutralising activity is not entirely mediated by antibodies von Gilli, F, Marnetto, F, Caldano, M, Valentino, P, Granieri, L, Di Sapio, A, Capobianco, M, Sala, A, Malucchi, S, Kappos, L, Lindberg, RLP, Bertolotto, A

Volltext

Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis von Gilli, F, Hoffmann, F, Sala, A, Marnetto, F, Caldano, M, Valentino, P, Kappos, L, Bertolotto, A, Lindberg, R L P

Volltext

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. Commentary von BERTOLOTTO, A, SALA, A, MALUCCHI, S, MARNETTO, F, CALDANO, M, DI SAPIO, A, CAPOBIANCO, M, GILLI, F, GIOVANNONI, G

Volltext

Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis von Gilli, F, Valentino, P, Caldano, M, Granieri, L, Capobianco, M, Malucchi, S, Sala, A, Marnetto, F, Bertolotto, A

Volltext

Interferon-[beta] bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice von van der Voort, LF, Kok, A, Oudejans, CBM, Caldano, M, Gilli, F, Bertolotto, A, Polman, CH, Killestein, J

Volltext

Qualitative and quantitative analysis of antibody response against IFN[beta] in patients with multiple sclerosis von Gilli, F, Hoffmann, F, Sala, A, Marnetto, F, Caldano, M, Valentino, P, Kappos, L, Bertolotto, A, Lindberg, RLP

Volltext